{"schema_version":"secwatch.filing_event.v1","accession":"0000950103-24-008385","form_type":"8-K","ticker":"ADCT","cik":"0001771910","company_name":"ADC Therapeutics SA","filed_at":"2024-06-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.998358+00:00","generated_at":"2026-06-01T04:22:49.603579+00:00","sec_items":["5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"ADC Therapeutics shareholders approve all 12 proposals at 2024 AGM, including director re-elections and compensation","bullets":["Shareholders approved management report, annual financial statements, and discharge of directors/executive committee for FY2023.","All nine directors reelected; compensation committee members, independent proxy, and PwC auditors also reelected.","Binding approval: board comp cap $2M; fixed exec comp cap $3M (FY2025); variable exec comp cap $10M (FY2024).","Advisory votes: compensation report and say-on-pay passed; shareholders recommended annual frequency, adopted by company.","Articles of association amended in six areas including shareholder rights, meetings, and conditional share capital flexibility."],"urls":{"canonical":"https://secwatch.observer/filing/0000950103-24-008385","json":"https://secwatch.observer/filing/0000950103-24-008385.json","markdown":"https://secwatch.observer/filing/0000950103-24-008385.md","text":"https://secwatch.observer/filing/0000950103-24-008385.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1771910/000095010324008385/0000950103-24-008385-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1771910/000095010324008385/dp212847_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:22:49.603579+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}